What is BioNexus KC?
BioNexus KC operates as a global leader dedicated to enhancing human and animal health via collaborative research and development. The organization convenes key stakeholders within the life sciences and healthcare sectors to propel impactful initiatives, with a particular emphasis on addressing rare diseases and promoting health equity. BioNexus KC actively supports early-stage projects through research grants, aiming to foster community health and wellness within the Kansas City region and to translate emerging technologies from concept to market.
How much funding has BioNexus KC raised?
BioNexus KC has raised a total of $2.4M across 3 funding rounds:
Debt
$81K
Grant
$2M
Grant
$311K
Debt (2021): $81K with participation from PPP
Grant (2023): $2M, investors not publicly disclosed
Grant (2024): $311K supported by Missouri Technology
Key Investors in BioNexus KC
Missouri Technology
The Missouri Technology Corporation (MTC) is a public-private partnership established by the Missouri General Assembly to enhance entrepreneurship and support the development of new high-tech companies. MTC primarily targets the life sciences and technology sectors, leveraging Missouri's agricultural heritage. The organization offers various programs, including venture capital investments, grants, and entrepreneurial ecosystem support to foster innovation. Its intended clients include emerging businesses and entrepreneurs in Missouri seeking resources and funding to grow their ventures.
What's next for BioNexus KC?
The recent major strategic investment positions BioNexus KC for accelerated growth and expanded impact. This capital infusion is expected to fuel further research into critical areas such as rare diseases and health equity, while also strengthening its commitment to community health initiatives in the Kansas City area. The organization's focus on interdisciplinary collaboration suggests a strategic roadmap centered on bringing novel technologies to fruition and solidifying its leadership in the life sciences sector.
See full BioNexus KC company page
